News | February 29, 2024
Chemex Global inaugurates state-of-the-art API plant in Guwahati
The plant will drive pharmaceutical innovation in the Northeastern India
The plant will drive pharmaceutical innovation in the Northeastern India
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The company is strongly committed to enhancing customer satisfaction and catering to the discerning needs of renowned pharmaceutical companies
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
The collaboration brings a seamless digital experience to more formulators worldwide
Subscribe To Our Newsletter & Stay Updated
